Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06569953 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chronic Pain After Thoracoscopic Pneumonectomy: A Multicenter, Randomized, Double-blind, Controlled Clinical Trial

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 27, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Collaborators revised (4)v3
  2. Start date changed from estimate of Aug 2024 to Aug 26, 2024
    • Collaborators revised (4)
    • Study title expanded, about 15 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to evaluate the efficacy and safety of liposomal Bupivacaine administered by paravertebral block for the treatment of acute and chronic pain after video-assisted thoracoscopic lobectomy.
Trial Details
NCT Number NCT06569953
Lead Sponsor The Second Affiliated Hospital of Chongqing Medical University
Collaborators: People's Hospital of Chongqing, LanZhou University, Xiangya Hospital of Central South University, Shapingba District People's Hospital of Chongqing
Conditions
(from sponsor)		 Acute Pain, Chronic Pain, Postoperative Pain
Related terms Acute Pain, Chronic Pain, Postoperative Pain
Enrollment 284 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov